Targeted Therapy Finder

Online App for Planning Melanoma Treatment Now Available for ASCO Members and Patients

ASCO has recently partnered with CollabRx to develop an innovative, web-based decision support tool that enables physicians and their patients to better understand emerging cancer therapies in melanoma, and to identify diagnostic tests, treatments, and clinical trials associated with the unique molecular profiles of patients’ tumors.

This new initiative is an effort to provide quality and timely information to ASCO members to help them deliver the highest quality care to their patients. The app, called the “Targeted Therapy Finder – Melanoma,” is available to health professionals via ASCO.org. People diagnosed with melanoma can utilize the free tool through Cancer.Net.